Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G. Duffy, Tim F. Greten, Jeremy L. Davis et al.|Journal of Hepatology|2016Cited by 817
Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetesF. W. Sum, K. Steiner, A. Gilbert et al.|Bioorganic & Medicinal Chemistry Letters|1999Cited by 25
Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew Leonard Laccetti, Matthew T. Campbell, Benjamin Garmezy et al.|Cancer Medicine|2021Cited by 19